‘Superhuman’ AI tool spots heart disease in less than 2 seconds

The National Health Service is initiating trials for an artificial intelligence tool designed to identify heart disease with extreme speed. According to reports from The Guardian and The Times, this software is described as 'superhuman' and is capable of spotting heart disease in less than two seconds. The system operates by analyzing facial data, with The Mirror specifying that the tool could diagnose both heart disease and high blood pressure following a face scan that lasts five seconds. The primary objective is to catch conditions that are otherwise undetectable through traditional means. Coverage across several major UK publications emphasizes the rapid nature of the diagnostic process.

The Telegraph describes the ability of the tool to catch undetectable heart disease in the 'blink of an eye,' while The Sun explicitly mentions that the NHS is trialing the AI to spot these conditions in just two seconds. The consistent framing across The Guardian, The Times, and other outlets centers on the speed and accuracy of the software, highlighting the potential for near-instantaneous screening in a medical setting. The context for this development lies in the difficulty of detecting certain types of heart disease before they become critical. By utilizing a brief face scan, the AI intends to identify markers of cardiovascular illness and hypertension that might be missed during standard examinations. The integration of this technology into the NHS represents a shift toward AI-driven preventative screening, aiming to reduce the time between the onset of a condition and its initial detection through automated facial analysis.

Future developments will depend on the results of these NHS trials. Watchers will be looking for data on how the five-second face scan performs across diverse patient populations and whether the 'superhuman' speed of the software translates to clinical reliability. The coverage indicates that the focus remains on the trial phase, meaning further reports will likely detail the scale of the rollout and the specific types of undetectable heart disease the AI is most effective at identifying.